Peptide overview
IGF-1 DES: research, legal status and who sells it
This page is information, not medical advice. IGF-1 DES is not approved as a medicine in the markets below unless stated. Doses on this site are those used in published studies or on official labels, never advice for anyone's own use.
- Also known as
- IGF-DES, DES(1-3)IGF-1, IGF-1 DES(1-3), des-(1-3)-IGF-1
- Category
- Truncated analogue of insulin-like growth factor 1 lacking the first three N-terminal residues
- Evidence level
- Preclinical (lab and animal studies)
- Price range
- $36.99/mg to $99.00/mg, median $74.99/mg across 8 vendors (compare)
- Our lab tests
- None yet (how testing will work)
Legal and regulatory status
| Where | Status |
|---|---|
| United States | No FDA-approved drug is DES(1-3)IGF-1; the only approved recombinant IGF-1 is mecasermin, which is native-sequence IGF-1, not this analogue [1]. |
| United Kingdom | No UK-licensed medicine is DES(1-3)IGF-1; the only IGF-1 medicine in the MHRA products database is Increlex (mecasermin), native-sequence recombinant IGF-1 [2]. |
| European Union | No medicine containing DES(1-3)IGF-1 is authorized in the EU, according to EMA's central and Article 57 product data [3][4]. |
| Canada | No product containing DES(1-3)IGF-1 appears in Health Canada's Drug Product Database [5]. |
| Australia | Not named individually; Australia's Poisons Standard lists insulin-like growth factors in Schedule 4, with possession without authority restricted under Appendix D (clause 5) [6]. |
| Sport (WADA) | IGF-1 and its analogues are prohibited at all times under section S2 [7][8]. |
We haven't published a full overview of IGF-1 DES yet. The legal status table and live prices on this page are current.
IGF-1 DES prices: cheapest listings
The five lowest $/mg listings out of 9. See all IGF-1 DES prices
| Vendor | Transparency | Product | Size | Price | $/mg | Stock | Vendor's page |
|---|---|---|---|---|---|---|---|
| Geo Peptides | 52 | IGF-1 DES 1,3 1mg (USA) | 1 mg | $37 | $36.99/mg | View | |
| Peak Lab Peptides | 83 | 2 mg | $77 | $38.50/mg | View | ||
| Amino Asylum (aminoasylumofficial.com) Red flags | 47 | 1 mg | $50 | $49.99/mg | Red flags | ||
| Swiss Chems FDA warning letter, Dec 2024 | 72 | 1 mg × 10 | $560 | $55.95/mg | Out of stock | View | |
| Swiss Chems FDA warning letter, Dec 2024 | 72 | 1 mg | $56 | $55.95/mg | Out of stock | View |
Sources
- Drugs@FDA: FDA-Approved Drugs (database searched by active ingredient). U.S. Food and Drug Administration. Accessed Oct 16, 2026
- MHRA Products: licensed-medicine search for "mecasermin". Medicines and Healthcare products Regulatory Agency (UK). Accessed Oct 16, 2026
- EMA medicines data: centrally authorised human medicines. European Medicines Agency. Accessed Oct 16, 2026
- EMA Article 57 product data: medicines authorised in the EU/EEA. European Medicines Agency. Accessed Oct 16, 2026
- Drug Product Database online query (searched by active ingredient). Health Canada. Accessed Oct 16, 2026
- Therapeutic Goods (Poisons Standard—October 2026) Instrument 2026 (F2026L01327, registered 30 September 2026). Federal Register of Legislation, Australian Government. Accessed Oct 16, 2026
- World Anti-Doping Code International Standard: Prohibited List 2026 (in force 1 January 2026). World Anti-Doping Agency. Accessed Oct 16, 2026
- Detection of LongR3-IGF-I, Des(1-3)-IGF-I, and R3-IGF-I using immunopurification and high resolution mass spectrometry for antidoping purposes (Mongongu et al., Drug Test Anal 2021). Drug Testing and Analysis / PubMed (NLM). Accessed Oct 16, 2026